IP6K1 and Cognitive impairment: Application of therapeutics, demonstrated to improve ischemia-induced disrupted spatial cognition and central neuronal cholinergic function [79], to this model were shown to reduce the elevated levels of cortical IHPK1, resulting in amelioration of the SAMP8 cognitive deficits [80].